Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

NCT02505945 is registered in ClinicalTrials.gov with Torax Medical Incorporated as lead sponsor.

NCT NCT02505945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02505945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease
Lead sponsor
Torax Medical Incorporated
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2015
Completion date
August 31, 2018
Enrollment
152 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

gerd gastroesophageal reflux disease